Development of Biomarkers or Biomarker Signatures for Neurological and Neuromuscular Disorders (R61/R33 Clinical Trial Optional)
This grant opportunity aims to support the discovery and preliminary evaluation of biomarkers and biomarker signatures to aid in developing treatments for neurological and neuromuscular disorders. The focus is on identifying and initially evaluating these biomarkers through biological, analytical, and clinical methods. While animal studies are allowed, research must also include initial human …
The overarching purpose of this Funding Opportunity Announcement (FOA) is to promote the discovery and/or early evaluation of strong candidate biomarkers and biomarker signatures that can be used as tools to facilitate the clinical development of neurotherapeutics and their use in clinical pract…
Funding Source
Dates
Documents
Secure Grant Funding 10x Faster
Scout delivers AI-powered grant writing paired with experts that's faster, more affordable, and built to win.
Already have an account? Sign In
Trusted by 500+ Happy Customers